The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo

JamesE. Crowe Jr., Valerie Randolph, BrianR. Murphy
  • Virus Research, January 1999, Elsevier
  • DOI: 10.1016/s0168-1702(98)00118-x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr James E Crowe